IBO’s first report of 2016 for new laboratories outlines the construction and opening of labs in various sectors, including government, academia and biotechnology. On page 4, a table detailing the establishment of selected labs can be found, including new labs in the pharmaceutical industry. Government Various countries in Asia have broken ground on or approved […]
Currency fluctuations and economic turbulence not only produced a shift among IBO’s 2015 list of the top 30 analytical and life science instrument, aftermarket and lab product companies, but also yielded a calendar year sales decline when translated into US dollars. Total sales for the top 30 companies (see page 6) as reported in US […]
This month, the US Office of Science and Technology Policy released a report regarding research infrastructure and instrumentation funding for fiscal 2017. The information in the report is liable to change, as the fiscal 2017 budget has yet to be determined; however, the report also includes budget allocations for R&D facilities construction and research instrumentation […]
US equity markets steadily advanced in March with the Dow Jones Industrial Average, S&P 500 and NASDAQ improving 7.1%, 6.6% and 6.8%, respectively. Investors reacted favorably to US Federal Reserve Chair Janet Yellen’s dovish stance, as she advocated a more cautious approach to policy changes due to the fragile global economic environment. Consequently, the US […]
Venlo, the Netherlands 3/29/16; Copenhagen, Denmark 3/29/16—QIAGEN has announced that it plans to submit a conditional voluntary takeover offer to Exiqon shareholders. QIAGEN will offer DKK 18 ($2.70 = DKK 6.67 = $1) per share, a 41.7% premium over Exiqon’s closing price on March 29, or DKK 683 million ($102 million). Publicly held Exiqon provides […]
Palo Alto, CA 3/18/16; Santa Clara, CA 3/20/16; Waltham, MA 3/20/16; Palo Alto, CA 3/21/16; Palo Alto, CA 3/22/16; Waltham, MA 3/22/16; Santa Clara, CA 3/23/16; Santa Clara, CA 3/28/16; Palo Alto, CA 3/28/16; Waltham, MA 3/28/16; Waltham, MA 3/31/16—On March 31, Affymetrix shareholders approved Thermo Fisher Scientific’s offer to acquire the company for $14 […]
Company Announcements For the fiscal half year ending September 2015, Oxford Instruments sales fell 5.8%, down 2.8% organically, to £164.8 million ($253.5 million) (see IBO 11/15/15). Growth was hampered by weak global Industrial Analysis sales within the Industrial Products segment, which fell 7.9% organically. While organic growth for the Nanotechnology Tools segment was marginally lower, […]
Bio-Rad Sees Improved Research Spending Fourth quarter 2015 sales for Bio-Rad Laboratories Life Science (LS) contracted 2.5% to $218.1 million to account for 38% of revenues. However, excluding currency, organic sales advanced 3.4%, led by demand for digital PCR, process media, cell biology and western blotting products. Geographically, organic growth was strongest in China, Europe […]
Agilent Posts Solid Quarter Agilent Technologies fiscal first quarter revenues ending January 31 improved 0.2%, 6.4% organically, to $1.03 billion (see page 12). Sales were slightly ahead of company expectations, driven by strength in the pharmaceutical, and clinical and diagnostics markets. Furthermore, academic and government sales returned to growth due to increased government spending in […]
In February, the S&P 500 and NASDAQ declined for the third consecutive month, sliding 0.4% and 1.2%, respectively. Meanwhile, the Dow Jones Industrial Average weathered the negative trend as it posted a modest gain of 0.3%. Equity markets were extremely volatile as a result of fluctuating oil prices and anxieties over global economic growth. Nevertheless, […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
